Bone reconstruction and/or augmentation with hydroxyapatite-fibrin glue: Personal experience and review of the literature

Italian Journal of Mineral and Electrolyte Metabolism

Volumn 13, Issue 1-2, 1999, Pages 5-18

  Marini, E ^a   Valdinucci, F ^a   Bonucci, E ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

Author keywords

Bone formation; Fibrin glue; Hydroxyapatite; Implants; Osteoconduction

Indexed keywords

BIOMATERIAL; BISPHOSPHONIC ACID DERIVATIVE; BONE MORPHOGENETIC PROTEIN; FIBRIN GLUE; GROWTH FACTOR; GROWTH HORMONE; HYDROXYAPATITE; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BONE BIOPSY; BONE GRAFT; BONE REGENERATION; HUMAN; IMPLANT; ORTHOPEDIC SURGERY; OSSIFICATION; PLASTIC SURGERY;

EID: 0033499088     PISSN: 11211709     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (214)

1. Ham AW, Harris WR. Repair and transplantation of bone. In: Bourne GH, editor. The biochemistry and physiology of bone. 2nd ed. New York: Academic Press, 1971:337.
2. Dioguardi D. Trapianti e innesti d'osso. Napoli: Idelson, 1989.
3. Jackson IT, Helden G, Marx R. Skull bone grafts in maxillofacial and craniofacial surgery. J Oral Maxillofac Surg 1986;44:949-55.
4. Oklund SA, Prolo DJ, Gutierrez RV, King SE. Quantitative comparisons of healing in cranial fresh autografts, frozen autografts and processed autografts, and allografts in canine skull defects. Clin Orthop 1986;205:269-91.
5. Begley CT, Doherty MJ, Mollan RAB, Wilson DJ. Comparative study of the osteoinductive properties of bioceramic, coral and processed bone graft substitute. Biomaterials 1995;16:1181-5.
6. Meffert RM, Langer B, Fritz ME. Dental implants: A review. J Periodontol 1992;63:859-70.
7. Costantino PD, Friedman CD. Synthetic bone graft substitutes. Otolaryngol Clin North Am 1994;27:1037-74.
8. Hollinger JO, Brekke J, Gruskin E, Lee D. Role of bone substitutes. Clin Orthop 1996;324:55-65.
9. Archer RS, Downes S, Kayser MV, Ali SY. The tissue responses to tricalcium phosphate ceramics in bone and marrow. Cells and Materials 1992;2:113-8.
10. Liu C, Wang W, Shen W, Chen T, Hu L, Chen Z. Evaluation of the biocompatibility of a nonceramic hydroxyapatite. J Endod 1997;23:490-3.
11. de Bruijn JD. Calcium phosphate biomaterials: Bone-bonding and biodegradation properties University of Leiden, 1993:9.
12. Decker B, Bartels H, Decker S. Relationships between endothelial cells, pericytes, and osteoblasts during bone formation in the sheep femur following implantation of tricalciumphosphate-ceramic. Anat Record 1995;242:310-20.
13. Franchi M, Vernole B, Cantoni E, Evangelisti A, Ruggeri A. La rigenerazione ossea in innesti dentali allogenici ed impianti alloplastici. Ricerche istologiche ed ultrastrutturali. Mondo Odontostomatol 1987;2:19-27.
14. Franchi M, De Pasquale V, Ruggeri A, Strocchi R. Tricalcium phosphate endosseous implants in dentistry: Ultrastructural findings. Bull Group Int Rech Sci Stomatol Odontol 1991;34:123-31.
15. Ruggeri A, Franchi M, Evangelisti A, De Pasquale V, Bigi A, Ripamonti A et al. Morphological studies of new bone formation favoured by β-TCMP implants. In: Pizzoferrato A, Marchetti PG, Ravaglioli A, Lee AJC, editors. Biomaterials and clinical applications. Amsterdam: Elsevier Science Publisher B.V., 1987:603.
16. Vicente V, Meseguer L, Martinez F, Galian A, Rodriguez J, Alcaraz M, Clavel M. Ultrastructural study of the osteointegration of bioceramics (whitlockite and composite β-TCP + collagen) in rabbit bone. Ultrastruct Pathol 1996;20:179-88.
17. Franchi M, Ruggeri A. β-TCP e β-TCMP quali osteoriproduttori. Dent Cadmos 1989;19:54-67.
18. Mors WA, Kaminski EJ. Osteogenic replacement of tricalcium phosphate ceramic implants in the dog palate. Archs Oral Biol 1975;20:365-7.
19. Strub JR, Gaberthuel TW, Firestone AR. Comparison of tricalcium phosphate and frozen allogenic bone implants in man. J Periodontol 1979;50:624-9.
20. Jarcho M. Calcium phosphate ceramics as hard tissue prosthetics. Clin Orthop 1981;157:259-78.
21. Snyder AJ, Levin MP, Cutright DE. Alloplastic implants of tricalcium phosphate ceramic in human periodontal osseous defects. J Periodontol 1984;55:273-7.
22. Barney VC, Levin MP, Adams DF. Bioceramic implants in surgical periodontal defects. A comparison study. J Periodontol 1986;57: 764-70.
23. Bowers GM, Vargo JW, Levy B, Emerson LK, Berquist JJ. Histologic observations following the placement of tricalcium phosphate implants in human intrabony defects. J. Periodontol 1986;57:286-7.
24. Heikkilä JT, Aho HJ, Yli-Urpo A, Happonen R-P, Aho AJ. Bone formation in rabbit cancellous bone defects filled with bioactive glass granules. Acta Orthop Scand 1995;66:463-7.
25. Höland W, Götz W, Carl G, Vogel W. Microstructure of mica glass-ceramics and interface reactions between mica glass-ceramics and bone. Cells Materials 1992;2:105-12.
26. Oonishi H, Kushitani S, Yasukawa E, Iwaki H, Hench LL, Wilson J et al. Particulate bioglass compared with hydroxyapatite as a bone graft substitute. Clin Orthop 1997;334:316-25.
27. Zamet JS, Darbar UR, Griffiths GS, Bulman JS, Brägger U, Bürgin W et al. Particulate bioglass® as a grafting material in the treatment of periodontal intrabony defects. J Clin Periodontol 1997;24:410-8.
28. Schmitt JM, Buck DC, Joh S-P, Lynch SE, Hollinger JO. Comparison of porous bone mineral and biologically active glass in critical-sized defects. J Periodontol 1997;68:1043-53.
29. Yukna RA. Clinical evaluation of coralline calcium carbonate as a bone replacement graft material in human periodontal osseous defects. J Periodontol 1994;65:177-85.
30. Vuola J, Göransson H, Böhling T, Asko-Seljavaara S. Bone marrow induced osteogenesis in hydroxyapatite and calcium carbonate implants. Biomaterials 1996;17:1761-6.
31. Pacharalambous SK, Anastasoff KI. Natural coral skeleton use as onlay graft for contour augmentation of the face. J Oral Maxillofac Surg 1993;22:260-4.
32. Guillemin G, Patat JL, Fournie J, Chetail M. The use of coral as a bone graft substitute. J Biomed Mater Res 1987;21:557-67.
33. Beeson WH. Plaster of Paris as an alloplastic implant in frontal sinus. Arch Otolaryngol Head Neck Surg 1981;107:664-9.
34. Fulmer NL, Bussard GM, Gampper TJ, Edlich RF. Anorganic bovine bone and analogs of bone mineral as implants for craniofacial surgery: A literature review. J Long-Term Effects Med Impl 1998;8:69-78.
35. Posner AS. Bone mineral and the mineralization process. In: Peck WA, editor. Bone and mineral research/5. Amsterdam: Elsevier Science Publisher, 1987:65.
36. Nagano M, Nakamura T, Kokubo T, Tanahashi M, Ogawa M. Differences on bone bonding ability and degradation behaviour in vivo between amorphous calcium phosphate and highly crystalline hydroxyapatite coating. Biomaterials 1996;17:1771-7.
37. Lemons JE. Ceramics: past, present, and future. Bone 1996;19: 121S-8S.
38. Sun J-S, Liu H-C, Chang WH-S, Li J, Lin F-H, Tai H-C. Influence of hydroxyapatite particle size on bone cell activities: an in vitro study. J Biomed Mater Res 1998;39:390-7.
39. Hott M, Noel B, Bernache-Assolant D, Rey C, Marie PJ. Proliferation and differentiation of human trabecular osteoblastic cells on hydroxyapatite. J Biomed Mater Res 1997;37:508-16.
40. Uchida A, Araki N, Shinto Y, Yoshikawa H, Kurisaki E, Ono K. The use of calcium hydroxyapatite ceramic in bone tumor surgery. J Bone Joint Surg 1990;72-B:298-302.
41. Okumura M, Ohgushi H, Tamai S, Shors EC. Primary bone formation in porous hydroxyapatite ceramic: A light and scanning electron microscopic study. Cells and Materials 1991;1:29-34.
42. Holmes RE, Hagler HK. Porous hydroxylapatite. A bone graft substitute in mandibular contour augmentation: A histometric study. J Oral Maxillofac Surg 1987;45:421-9.
43. Holmes RE, Wardrop RW, Wolford LM. Hydroxylapatite as a bone graft substitute in orthognatic surgery: Histologic and histometric findings. J Oral Maxillofac Surg 1988;46:661-71.
44. Braye F, Weber G, Irigaray JL, Frayssinet P. Osseointegration in cortical sheep bone of calcium phosphate implants evaluated by PIXE method and histology. J Biomed Mater Res 1997;36:315-24.
45. Frayssinet P, Braye F, Weber G. Analysis of sections of implanted macroporous calcium phosphate bone substitutes by proton-induced X-emission method and energy-dispersive spectrometry. Scanning 1997;19:253-7.
46. Jaffe WL, Scott DF. Total hip arthroplasty with hydroxyapatite-coated prostheses. J Bone Joint Surg 1996;78-A:1918-34.
47. Esposito M, Hirsch J-M, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants (I). Success criteria and epidemiology. Eur J Oral Sci 1998;106: 527-51.
48. Maruyama M. Hydroxyapatite clay used to fill the gap between implant and bone. J Bone Joint Surg 1995;77-B:213-8.
49. Clemens JAM, Klein CPAT, Vriesde RC, Rozing PM, De Groot K. Healing of large (2 mm) gaps around calcium phosphate-coated bone implants: A study in goats with a follow-up of 6 months. J Biomed Mater Res 1998;40:341-9.
50. Kitsugi T, Yamamuro T, Takeuchi H, Ono M. Bonding behaviour of three types of hydroxyapatite with different sintering temperatures implanted in bone. Clin Orthop 1988;234:280-90.
51. Hoogendoorn HA, Renooij W, Akkermans LMA, Visser W, Wittebol P. Long-term study of large ceramic implants (porous hydroxyapatite) in dog femora. Clin Orthop 1984;187:281-8.
52. Ripamonti U. Calvarial reconstruction in baboons with porous hydroxyapatite. J Craniofac Surg 1992;3:149-59.
53. Costantino PD, Friedman CD, Jones K, Chow LC, Sisson GA. Experimental hydroxyapatite cement cranioplasty. Plast Reconstruct Surg 1992;90:174-85.
54. Lykins CL, Friedman CD, Costantino PD, Horioglu R. Hydroxyapatite cement in craniofacial skeletal reconstruction and its effects on the developing craniofacial skeleton. Arch Otolaryngol Head Neck Surg 1998;124:153-9.
55. Bernard SL, Picha GJ. The use of coralline hydroxyapatite in a "biocomposite" free flap. Plastic Reconstruct Surg 1991;87:96-105.
56. Grenga TE, Zins JE, Bauer TW. The rate of vascularization of coral-line hydroxyapatite. Plastic Reconstruct Surg 1989;84:245-9.
57. Hollinger J, Chaudhari A. Bone regeneration materials for the mandibular and craniofacial complex. Cells Materials 1992;2: 143-51.
58. Desjardins RP. Hydroxyapatite for alveolar ridge augmentation: Indications and problems. J Prosth Dent 1985;54:374-83.
59. Marshall SG. The combined use of endosseous dental implants and collagen/hydroxylapatite augmentation procedures for reconstruction/augmentation of the edentulous and atrophic mandible: A preliminary report. Oral Surg Oral Med Oral Pathol 1989;68: 517-26.
60. Mehlisch DR. Collagen/hydroxylapatite implant for augmenting deficient alveolar ridges: A 24 month clinical and histologic summary. Oral Surg Oral Med Oral Pathol 1989;68:505-16.
61. Doi Y, Horiguchi T, Moriwaki Y, Kitago H, Kajimoto T, Iwayama Y. Formation of apatite-collagen complexes. J Biomed Mater Res 1996;31:43-9.
62. Johnson KD, Frierson KE, Keller TS, Cook C, Scheinberg R, Zerwekh J et al. Porous ceramics as bone graft substitutes in long bone defects: A biomechanical, histological, and radiographic analysis. J Orthop Res 1996;14:351-69.
63. Byrd HS, Hobar PC, Shewmake K. Augmentation of craniofacial skeleton with porous hydroxyapatite granules. Plast Reconstr Surg 1993;91:15-22.
64. th National Congress of the Italian Society of Plastic, Reconstructive and Estetic Surgery. Bologna: Monduzzi Editore S.p.A., 1988:155.
65. Fortunato G, Poladas G, Nisii A, Mundula P, Pistilli R, Piccolino P et al. Idrossiapatite e colla di fibrina nella chirurgia ricostruttiva ed estetica cranio-facciale. Medic Estet 1995;19:167-70.
66. Bonucci E, Marini E, Valdinucci F, Fortunato G. Osteogenic response to hydroxyapatite-fibrin implants in maxillofacial bone defects. Eur J Oral Sci 1997;105:557-61.
67. Fortunato G, Marini E, Valdinucci F, Bonucci E. Long-term results of hydroxyapatite-fibrin glue implantation in plastic and reconstructive craniofacial surgery. J Cranio-Maxillofac Surg 1997;25:124-35.
68. Marini E, Valdinucci F, Silvestrini G, Moretti S, Carlesimo M, Poggio C et al. Morphological investigations on bone formation in hydroxyapatite-fibrin implants in human maxillary and mandibular bone. Cells Materials 1994;4:231-46.
69. Bonucci E, Marini E, Valdinucci F. Impianto di idrossiapatite e colla di fibrina: Risultati clinici su circa 1800 casi. Riv Odont 1994;13:1-19.
70. White RA, Weber JN, White EW. Replamineform: A new process for preparing porous ceramic, metal, and polymer prosthetic materials. Science 1972;176:922-4.
71. Tsuruga E, Takita H, Itoh H, Wakisaka Y, Kuboki Y. Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis. J Biochem 1997;121:317-24.
72. De Lange GL, De Putter C, De Groot K, Burger EH. A clinical, radiographic, and histological evaluation of permucosal dental implants of dense hydroxylapatite in dogs. J Dent Res 1989;68: 509-18.
73. Williams CW, Meyers JF, Robinson RR. Hydroxyapatite augmentation of the anterior portion of the maxilla with a modified transpositional flap technique. Oral Surg Oral Med Oral Pathol 1991;72:395-9.
74. Kamakura S, Sasano Y, Nakamura M, Suzuki O, Ohki H, Kagayama M et al. Initiation of alveolar ridge augmentation in the rat mandible by subperiosteal implantation of octocalcium phosphate. Archs Oral Biol 1996;41:1029-38.
75. Piecuch JF, Topazian RG, Skoly S, Wolfe S. Experimental ridge augmentation with porous hydroxyapatite implants. J Dent Res 1983;62:148-54.
76. Holmes RE. Bone regeneration within a coralline hydroxyapatite implant. Plast Reconstr Surg 1979;63:626-33.
77. Mora F, Ouhayoun JP. Clinical evaluation of natural coral and porous hydroxyapatite implants in periodontal bone lesions: Results of a 1-year follow-up. J Clin Periodontol 1995;22:877-84.
78. Kenney EB, Lekovic V, Han T, Carranza FAJ, Dimitrijevic B. The use of a porous hydroxylapatite implant in periodontal defects. I. Clinical results after six months. J Periodontol 1985;56:82-8.
79. Beck-Coon RJ, Newton CW, Kafrawy AH. An in vivo study of the use of a nonresorbable ceramic hydroxyapatite as an alloplastic graft material in periapical surgery. Oral Surg Oral Med Oral Pathol 1991;71:483-8.
80. Quinones CR, Hurzeler MB, Schupbach P, Arnold DR, Strub JR, Caffesse RG. Maxillary sinus augmentation using different grafting materials and dental implants in monkeys. Part IV. Evaluation of hydroxyapatite-coated implants. Clin Oral Implants Res 1997;8:497-505.
81. Esposito S, Fortunato G, Pistilli R, Salvatore P, Mundula P, Fortunato R et al. L'uso dell'impianto alloplastico nella ricostruzione della base cranica. In: Iannetti G, editor. Chirurgia maxillo facciale. Bologna: Monduzzi Editore S.p.A., 1993:215.
82. Rosen HM, McFarland MM. The biologic behavior of hydroxyapatite implanted into the maxillofacial skeleton. Plastic Reconstruct Surg 1990;85:718-23.
83. Salyer KE, Craig DH. Porous hydroxyapatite as an onlay bone-graft substitute for maxillofacial surgery. Plastic Reconstruct Surg 1989;84:236-44.
84. Green JP, Wojno TH, Wilson MW, Grossniklaus HE. Bone formation in hydroxyapatite orbital implants. Am J Ophtalmol 1995;120:681-82.
85. Satoh K, Nakatsuka K. Simplified procedure for aesthetic improvement of facial contour by maxillary augmentation using a porous hydroxyapatite graft for maxillofacial deformity. Plast Recontruct Surg 1996;97:338-44.
86. Shindo ML, Costantino PD, Friedman CD, Chow LC. Facial skeletal augmentation using hydroxyapatite cement. Arch Otolaryngol Head Neck Surg 1993;119:185-90.
87. Grigolato P, Ferrari Parabita G, Derada Troletti G, Zanetti U, Berenzi A, Marocolo D. L'impiego della idrossiapatite di calcio in chirurgia oro-maxillo-facciale. Min Stomat 1984;33:1-8.
88. Marker P, Siemssen SJ, Basholt L. Osseointegrated implants for prosthetic rehabilitation after treatment of cancer of the oral cavity. Acta Oncol 1997;36:37-40.
89. Burstein FD, Cohen SR, Hudgins R, Boydston W. The use of porous granular hydroxyapatite in secondary orbitocranial reconstruction. Plast Reconstr Surg 1997;100:869-74.
90. Nunes CR, Simske SJ, Sachdeva R, Wolford LM. Long-term ingrowth and apposition of porous hydroxylapatite implants. J Biomed Mater Res 1997;36:560-3.
91. Sekundo W, Seifert P. Hydroxyapatite orbital implant. A light- and electron-microscopic and immunohistochemical study. Ophtalmology 1998;105:539-43.
92. De Groot K, Jansen JA, Wolke JGC, Klein CPAT, Van Blitterswijk CA. Development in bioactive coatings. In: Geesink RGT, Manley MT, editors. Hydroxylapatite coating in orthopaedic surgery. New York: Raven Press, 1993:49.
93. Rinonapoli G, Doria C, Sbernardori MC, Merola F, De Santis V, Carreri G. Riassorbimento dell'idrossiapatite da superfici metalliche: Osservazioni al microscopio elettronico a scansione. Giorn It Ortop Traumat 1997;23:341-8.
94. Wang JW, Wicklund BH, Gustilo RB, Tsukayama DT. Prosthetic metals interfere with the functions of human osteoblast cells in vitro. Clin Orthop 1997;339:216-26.
95. McPherson FJ, Dorr LD, Gruen TA, Saberi MT. Hydroxyapatite-coated proximal ingrowth femoral stems. A matched pair control study. Clin Orthop 1995;315:223-30.
96. Rothman RH, Hozack WJ, Ranawat A, Moriarty L. Hydroxyapatite-coated femoral stems. A matched-pair analysis of coated and uncoated implants. J Bone Joint Surg 1996;78-A:319-24.
97. Dalton JE, Cook SD, Thomas KA, Kay JF. The effect of operative fit and hydroxyapatite coating on the mechanical and biological response to porous implants. J Bone Joint Surg 1995;77-A:97-110.
98. Frayssinet P, Hardy D, Hanker JS, Giammara BL. Natural history of bone response to hydroxyapatite-coated hip prostheses implanted in humans. Cells Materials 1995;5:125-38.
99. Furlong RJ, Osborn JF. Fixation of hip prostheses by hydroxyapatite ceramic coatings. J Bone Joint Surg 1991;73-B:741-5.
100. Hardy DCR, Frayssinet P, Guilhem A, Lafontaine MA, Delince PE. Bonding of hydroxyapatite-coated femoral prostheses. Histopathology of specimens from four cases. J Bone Joint Surg 1991;73-B:732-40.
101. Soballe K, Brockstedt-Rasmussen H, Hansen ES. Hydroxyapatite coating modifies implant membrane formation. Controlled micromotion studied in dogs. Acta Orthop Scand 1992;63:128-40.
102. Soballe K, Hansen ES, Brockstedt-Rasmussen H, Pedersen CM, Bunger C. Bone graft incorporation around titanium-alloy and hydroxyapatite-coated implants in dogs. Clin Orthop 1992;274: 282-93.
103. Oonishi H, Yamamoto M, Ishimaru H, Tsuji E, Kushitani S, Aono M et al. The effect of hydroxyapatite coating on bone growth into porous titanium alloy implants. J Bone Joint Surg 1989;71-B:213-6.
104. Merolli A, Tranquilli Leali P, Palmacci O, Caruso L, Perrone V. Il ruolo del rivestimento in idrossiapatite nelle protesi d'anca: Considerazioni sperimentali e cliniche. G It Ortop Traumatol 1996;22:119-21.
105. D'Antonio JA, Capello WN, Manley MT. Remodeling of bone around hydroxyapatite-coated femoral stems. J Bone Miner Res 1996;78-A:1226-34.
106. Takeshita F, Iyama S, Ayukawa Y, Akedo H, Suetsugu T. Study of bone formation around dense hydroxyapatite implants using light microscopy, image processing and confocal laser scanning microscopy. Biomaterials 1997;18:317-22.
107. Yan W-Q, Nakamura T, Kawanabe K, Nishigochi S, Oka M, Kokubo T. Apatite layer-coated titanium for use as bone bonding implants. Biomaterials 1997;18:1185-90.
108. Benazzo F, Todesca A, Mora R, Mosconi M, Ceciliani L. Biocompatibilità e osteoconduzione di superfici accoppiate idrossiapatite e titanio: Studio sperimentale. G It Ortop Traumatol 1997;23:329-39.
109. Stentz WC, Mealey BL, Gunsolley JC, Waldrop TC. Effects of guided bone regeneration around commercially pure titanium and hydroxyapatite-coated dental implants. II. Histologic analysis. J Periodontol 1997;68:933-49.
110. Pazzaglia UE, Brossa F, Zatti G, Chiesa R, Andrini L. The relevance of hydroxyapatite and spongious titanium coatings in fixation of cementless stems. An experimental comparative study in rat femur employing histological and microangiographic techniques. Arch Orthop Traumatol Surg 1998;117:279-85.
111. Jones JD, Saigusa M, Van Sickels JE, Tiner BD, Gardner WA. Clinical evaluation of hydroxyapatite-coated titanium plasma-sprayed and titanium plasma-sprayed cylinder dental implants: A preliminary report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:137-41.
112. Capello WN, D'Antonio JA, Feinberg JR, Manley MT. Hydroxyapatite-coated total hip femoral components in patients less than fifty years old. Clinical and radiographic results after five to eight years of follow-up. J Bone Joint Surg 1997;79-A:1023-9.
113. Overgaard S, Lind M, Glerup H, Grundvig S, Bunger C, Soballe K. Hydroxyapatite and fluorapatite coatings for fixation of weight loaded implants. Clin Orthop 1997;336:286-96.
114. Önsten I, Nordqvist A, Carlsson AS, Besjakov J, Shott S. Hydroxyapatite augmentation of the porous coating improves fixation of tibial components. A randomised RSA study in 116 patients. J Bone Joint Surg 1998;80-B:417-25.
115. Moroni A, Aspenberg P, Toksvig-Larsen S, Falzarano G, Giannini S. Enhanced fixation with hydroxyapatite coated pins. Clin Orthop 1998;346:171-7.
116. Linkhart TA, Mohan S, Baylink DJ. Growth factors for bone growth and repair: IGF, TGFb and BMP. Bone 1996;19;1S-12S.
117. Kawanabe K, Okada Y, Matsusue Y, Iida H, Nakamura T. Treatment of osteomyelitis with antibiotic-soaked porous glass ceramic. J Bone Joint Surg 1998;80-B:527-30.
118. Gautier H, Guicheux J, Grimandi G, Faivre-Chauvet A, Daculsi G, Merle C. In vitro influence of apatite-granule-specific area on human growth hormone loading and release. J Biomed Mater Res 1998;40:606-13.
119. Mundy GR. Regulation of bone formation by bone morphogenetic proteins and other growth factors. Clin Orthop 1996;323:24-8.
120. Wozney JM, Rosen V, Byrne M, Celeste AJ, Moutsatsos I, Wang EA. Growth factors influencing bone development. J Cell Sci 1990;13:149-56.
121. Urist MR. Bone morphogenetic protein: The molecularization of skeletal system development. J Bone Miner Res 1997;12:343-6.
122. Levine JP, Bradley J, Turk AE, Ricci JL, Benedict JJ, Steiner G et al. Bone morphogenetic protein promotes vascularization and osteoinduction in preformed hydroxyapatite in the rabbit. Ann Plast Surg 1997;39:158-68.
123. Takaoka K, Nakahara H, Yoshikawa H, Masuhara K, Tsuda T, Ono K. Ectopic bone induction on and in porous hydroxyapatite combined with collagen and bone morphogenetic protein. Clin Orthop 1988;234:250-4.
124. Missana L, Nagai N, Kuboki Y. Comparative histological studies of bone and cartilage formations induced by various BMP-carrier composites. Jpn J Oral Biol 1994;36:9-19.
125. Urist MR, Lietze A, Dawson E. β-tricalcium phosphate delivery system for bone morphogenetic protein. Clin Orthop 1984;187:277-80.
126. Breitbart AS, Staffenberg DA, Thorne CHM, Glat PM, Cunningham NS, Reddi AH et al. Tricalcium phosphate and osteogenin: A bioactive onlay bone graft substitute. Plast Reconstr Surg 1995;96: 699-708.
127. Ono I, Gunji H, Kaneko F, Saito T, Kuboki Y. Efficacy of hydroxyapatite ceramic as a carrier for recombinant human bone morphogenetic protein. J Craniofac Surg 1995;6:238-44.
128. Ono I, Gunji H, Suda K, Kaneko F, Murata M, Saito T et al. Bone induction of hydroxyapatite combined with bone morphogenetic protein and covered with periosteum. Plast Reconstr Surg 1995;95:1265-72.
129. Ono I, Ohura T, Murata M, Yamaguchi H, Ohnuma Y, Kuboki Y. A study on bone induction in hydroxyapatite combined with bone morphogenetic protein. Plast Reconstruct Surg 1992;90:870-9.
130. Ripamonti U, Ma S-S, van der Heever B, Reddi HA. Osteogenin, a bone morphogenetic protein, adsorbed on porous hydroxyapatite substrata, induces rapid bone differentiation in calvarial defects of adult primates. Plast Reconstr Surg 1992;90:382-93.
131. Miller TA, Ishida K, Kobayashi M, Wollman JS, Turk AE, Holmes RE. The induction of bone by an osteogenic protein and the conduction of bone by porous hydroxyapatite: B laboratory study in the rabbit. Plastic Reconstr Surg 1991;87:87-95.
132. Kuboki Y, Saito T, Murata M, Takita H, Mizuno M, Inoue M et al. Two distinctive BMP-carriers induce zonal chondrogenesis and membranous ossification, respectively; geometrical factors of matrices for cell-differentiation. Connect Tissue Res 1995;32: 219-26.
133. Mayer M, Hollinger J, Ron E, Wozney J. Maxillary alveolar cleft repair in dogs using recombinant human bone morphogenetic protein-2 and a polymer carrier. Plast Reconstr Surg 1996;98: 247-59.
134. Aspenberg P, Jeppsson C, Wang J-S, Bostrom M. Transforming growth factor beta and bone morphogenetic protein 2 for bone ingrowth: A comparison using bone chambers in rats. Bone 1996;19:499-503.
135. Gao TJ, Lindholm TS, Kommonen B, Ragni P, Paronzini A, Lindholm TC et al. Enhanced healing of segmental tibial defects in sheep by a composite bone substitute composed of tricalcium phosphate cylinder, bone morphogenetic protein, and type IV collagen. J Biomed Mater Res 1996;32:505-12.
136. Missana L, Nagai N, Kuboki Y. Comparative histological studies of bone and cartilage formations induced by various BMP-carrier composites. Jpn Oral Biol 1994;36:9-19.
137. Sasano Y, Mizoguchi I, Takahashi I, Kagayama M, Saito T, Kuboki Y. BMPs induce endochondral ossification in rats when implanted ectopically within a carrier made of fibrous glass membrane. Anat Record 1997;247:472-8.
138. Zegzula HD, Buck DC, Brekke J, Wozney JM, Hollinger JO. Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein). J Bone Joint Surg 1997;79-A:1778-90.
139. Kuboki Y, Takita H, Kobayashi D, Tsuruga E, Inoue M, Murata M et al. BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures: Topology of osteogenesis. J Biomed Mater Res 1998;39:190-9.
140. Gao TJ, Lindholm TS, Kommonen B, Ragni P, Paronzini A, Lindholm TC et al. The use of a coral composite implant containing bone morphogenetic protein to repair a segmental tibial defect in sheep. Int Orthop 1997;21:194-200.
141. Koempel JA, Patt BS, O'Grady K, Wozney J, Toriumi DM. The effect of recombinant human bone morphogenetic protein-2 on the integration of porous hydroxyapatite implants with bone. J Biomed Mater Res 1998;41:359-63.
142. Ono I, Tateshita T, Inoue M, Kuboki Y. In vivo strength enhancement of hydroxyapatite combined with rhBMP-2. J Bone Miner Metab 1998;16:81-7.
143. Kotani S, Yamamuro T, Nakamura T, Kitsugi T, Fujita Y, Kawanabe K et al. Enhancement of bone bonding to bioactive ceramics by demineralized bone powder. Clin Orthop 1992;278:226-34.
144. Ripamonti U, Van Den Heever B, Sampath TK, Tucker MM, Rueger DC, Reddi AH. Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, Bone Morphogenetic Protein-7). Growth Factors 1996;13: 273-89.
145. el Deeb M, Hosny M, Sharawy M. Osteogenesis in composite grafts of allogenic demineralized bone powder and porous hydroxylapatite. J Oral Maxillofac Surg 1989;47:50-6.
146. Damien CJ, Parsons JR, Prewett AB, Huismans F, Shors EC, Holmes RE. Effect of mineralized bone matrix on bone growth within a porous HA material: Histologic and histometric study. J Biomater Appl 1995;9:275-88.
147. Cole BJ, Bostrom MPG, Pritchard TL, Sumner DR, Tomin E, Lane JM et al. Use of bone morphogenetic protein 2 on ectopic porous coated implants in the rat. Clin Orthop 1997;345:219-28.
148. Arnaud E, Morieux C, Wybier M, De Vernejoul MC. Potentiation of transforming growth factor (TGF-b1) by natural coral and fibrin in a rabbit cranioplasty model. Calcif Tissue Int 1994;54: 493-8.
149. Lind M, Overgaard S, Ongpipattanakul B, Nguyen T, Bunger C, Soballe K. Transforming growth factor-p1 stimulates bone ongrowth to weight-loaded tricalcium phosphate coated implants. J Bone Joint Surg 1996;78B:377-82.
150. Lind M, Overgaard S, Soballe K, Nguyen T, Ongpipattanakul B, Biinger C. Transforming growth factor-p1 enhances bone healing to unloaded tricalcium phosphate coated implants: An experimental study in dogs. J Orthop Res 1996;14:343-50.
151. Arm DM, Tencer AF, Bain SD, Celino D. Effect of controlled release of platelet-derived growth factor from a porous hydroxyapatite implant on bone ingrowth. Biomaterials 1996;17:703-9.
152. Wang J-S, Aspenberg P. Basic fibroblast growth factor promotes bone ingrowth in porous hydroxyapatite. Clin Orthop 1996;333:252-60.
153. Ono I, Tateshita T, Takita H, Kuboki Y. Promotion of the osteogenetic activity of recombinant human bone morphogenetic protein by basic fibroblast growth factor. J Craniofac Surg 1996;7:418-25.
154. Guicheux J, Grimandi G, Trecant M, Faivre A, Takahashi S, Daculsi G. Apatite as carrier for growth hormone: In vitro characterization of loading and release. J Biomed Mater Res 1997;34:165-70.
155. Guicheux J, Gauthier O, Aguado E, Pilet P, Couillaud S, Jegou D et al. Human growth hormone locally released in bone sites by calcium-phosphate biomaterial stimulates ceramic bone substitution without systemic effects: A rabbit study. J Bone Miner Res 1998;13:739-48.
156. Guicheux J, Gauthier O, Aguado E, Heymann D, Pilet P, Couillaud S et al. Growth hormone-loaded macroporous calcium phosphate ceramic; in vitro biopharmaceutical characterization and preliminary in vivo study. J Biomed Mater Res 1998;40:560-6.
157. Denissen H, Van Beek E, van den Bos T, De Blieck J, Klein C, Van Den Hooff A. Degradable bisphosphonate-alkaline phosphatase-complexed hydroxyapatite implants in vitro. J Bone Miner Res 1997;12:290-7.
158. Burwell RG. The function of bone marrow in the incorporation of a bone graft. Clin Orthop 1985;200:125-41.
159. Sun J-S, Tsuang Y-H, Liao CJ, Liu H-C, Hang Y-S, Lin F-H. The effects of calcium phosphate particles on the growth of osteoblasts. J Biomed Mater Res 1997;37:324-34.
160. Rickard DJ, Kassem M, Hefferan TE, Sarkar G, Spelsberg TC, Riggs BL. Isolation and characterization of osteoblast precursor cell from human bone marrow. J Bone Miner Res 1996;11:312-24.
161. Owen M. The origin of bone cells in the postnatal organism. Arthr Rheumat 1980;23:1073-80.
162. Ozawa S, Kasugai S. Evaluation of implant materials (hydroxyapatite, glass-ceramics, titanium) in rat bone marrow stromal cell culture. Biomaterials 1996;17:23-9.
163. Sempuku T, Ohgushi H, Okumura M, Tamai S. Osteogenic potential of allogenic rat marrow cells in porous calcium phosphate ceramics: A preliminary study. Bioceramics 1996;8:397-401.
164. Yoshikawa T, Ohgushi H, Okumura M, Tamai S, Dohi Y, Moriyama T. Biochemical and histological sequences of membranous ossification in ectopic site. Calcif Tissue Int 1992;50:184-8.
165. Takaoka T, Okumura M, Ohgushi H, Inoue K, Takakura Y, Tamai S. Histological and biochemical evaluation of osteogenic response in porous hydroxyapatite coated alumina ceramics. Biomaterials 1996;17:1499-505.
166. Chehroudi B, Ratkay J, Brunette DM. The role of implant surface geometry on mineralization in vivo and in vitro; a transmision and scanning electron microscopic study. Cells Materials 1992;2:89-104.
167. Reddi AH, Huggins CB. Influence of geometry of transplanted tooth and bone on transformation of fibroblasts. Proc Soc Exp Biol Med 1973;143:634-7.
168. Chang Y-S, Oka M, Nakamura T, Gu H-O. Bone remodeling around implanted ceramics. J Biomed Mater Res 1996;30:117-24.
169. Wheeler DL, Stokes KE, Hoellrich RG, Chamberland DL, McLoughlin SW. Effect of bioactive glass particle size on osseous regeneration of cancellous defects. J Biomed Mater Res 1998;41:527-33.
170. Magan A, Ripamonti U. Geometry of porous hydroxyapatite implants influences osteogenesis in baboons (Papio ursinus). J Craniofac Surg 1996;7:71-8.
171. Gao T-J, Tuominen TK, Lindholm TS, Kommonen B, Lindholm TC. Morphological and biochemical difference in healing in segmental tibial defects implanted with Biocoral or tricalcium phosphate cylinders. Biomaterials 1997;18:219-23.
172. Costantino PD, Friedman CD, Jones K, Chow LC, Pelzer HJ, Sisson GA. Hydroxyapatite cement I. Basic chemistry and histologic properties. Arch Otolaryngol Head Neck Surg 1991;117: 379-84.
173. Sasano Y, Kamakura S, Nakamura M, Suzuki O, Mizoguchi I, Akita H et al. Subperiosteal implantation of octocalcium phosphate (OCP) stimulates both chondrogenesis and osteogenesis in the tibia, but only osteogenesis in the parietal bone of a rat. Anat Record 1995;242:40-6.
174. Overgaard S, Soballe K, Josephsen K, Hansen ES, Bünger C. Role of different loading conditions on resorption of hydroxyapatite coating evaluated by histomorphometric and stereological methods. J Orthop Res 1996;14:888-94.
175. Ripamonti U. Osteoinduction in porous hydroxyapatite implanted in heterotopic sites of different animal models. Biomaterials 1996;17:31-5.
176. Yang Z, Yuan H, Tong W, Zou P, Chen W, Zhang X. Osteogenesis in extraskeletally implanted porous calcium phosphate ceramics: Variability among different kinds of animals. Biomaterials 1996;17:2131-7.
177. Inoue K, Ohgushi H, Yoshikawa T, Okumura M, Sempuku T, Tamai S et al. The effect of aging on bone formation in porous hydroxyapatite: Biochemical and histological analysis. J Bone Miner Res 1997;12:989-94.
178. Jabs ADJ, Wider TM, DeBellis J, Hugo NE. The effect of fibrin glue on skin grafts in infected sites. Plastic Reconstruct Surg 1992;89:268-71.
179. Thompson, Davis TW. The addition of antibiotics to fibrin glue. Southern Med J 1997;90: 681-4.
180. Romanos GE, Strub JR. Effect of Tissucol on connective tissue matrix during wound healing: An immunohistochemical study in rat skin. J Biomed Mater Res 1998;39:462-8.
181. Pini Prato GP, Cortellini P, Clauser C, Guazzini S. Basi biologiche della sintesi tissutale con colla di fibrina umana. Minerva Stomatol 1983;32:903-14.
182. Frayssinet P, Rouquet N, Tourenne F, Pages J, Hardy D, Bonel G. Cell-degradation of calcium phosphate ceramics. Cells Materials 1993;3:383-94.
183. Davies JE, Shapiro G, Lowenberg BF. Osteoclastic resorption of calcium phosphate ceramic thin films. Cells Materials 1993;3: 245-56.
184. Dersot JM, Colombier ML, Lafont J, Baroukh B, Septier D, Saffar JL. Multinucleated giant cells elicited around hydroxyapatite particles implanted in craniotomy defects are not osteoclasts. Anat Record 1995;242:166-76.
185. Dersot JM, Septier D, Llorens A, Saffar JL. Multinucleated giant cells-hydroxyapatite interactions: A time-related quantitative study in a rat skull defect. Cells Materials 1993;3:395-405.
186. Wada T, Hhara K, Ozawa H. Ultrastructural and histochemical study of β-tricalcium phosphate resorbing cells in periodontium of dogs. J Periodont Res 1989;24:391-401.
187. Takeshita N, Akagi T, Yamasaki M, Ozeki T, Nojima T, Hiramatsu YA et al. Osteoclastic features of multinucleated giant cells responding to synthetic hydroxyapatite implanted in rat jaw bone. J Electron Microsc 1992;41:141-6.
188. Glowacki J, Jasty M, Goldring S. Comparison of multinucleated cells elicited in rats by particulate bone, polyethylene, or polymethylmethacrylate. J Bone Miner Res 1986;1:327-31.
189. de Bruijn JD, van Blitterswijk CA, Davies JE. Initial bone matrix formation at the hydroxyapatite interface in vivo. J Biomed Mater Res 1995;29:89-99.
190. McKee MD, Nanci A. Osteopontin at mineralized tissue interfaces in bone, teeth, and osseointegrated implants: Ultrastructural distribution, and implications for mineralized tissue formation, turnover, and repair. Microsc Res Techn 1996;33:141-64.
191. Kawaguchi H, McKee MD, Okamoto H, Nanci A. Immunocytochemical and lectin-gold characterization of the interface between alveolar bone and implanted hydroxyapatite in the rat. Cells Materials 1993;3:337-50.
192. Ayukawa Y, Takeshita F, Inoue T, Yoshinari M, Shimono M, Suetsugu T et al. An immunoelectron microscopic localization of noncollagenous bone proteins (osteocalcin and osteopontin) at the bone-titanium interface of rat tibiae. J Biomed Mater Res 1998;41:111-9.
193. Davies JE. In vitro modeling of the bone/implant interface. Anat Record 1996;245:426-45.
194. Okamoto K, Matsuura T, Hosokawa R, Akagawa Y. RGD peptides regulate the specific adhesion scheme of osteoblasts to hydroxyapatite but not to titanium. J Dent Res 1998;77:481-7.
195. Rodan G, Rodan SB. Expression of the osteoblastic phenotype. In: Peck WA, editor. Bone and mineral research/2. Amsterdam: Elsevier Science Publisher, 1983:244.
196. Bonucci E. The structural basis of calcification. In: Ruggeri A, Motta PM, editors. Ultrastructure of the connective tissue matrix. Boston: Martinus Nijhoff Publishing, 1984:165.
197. Meijer HJ, Steen WH, Bosman F, Wittkampf AR. Radiographic evaluation of mandibular augmentation with prefabricated hydroxylapatite/fibrin glue implants. J Oral Maxillofac Surg 1997;55: 138-44.
198. Piattelli A, Piattelli M, Romasco N, Trisi P. Histochemical and laser scanning microscopy characterization of the hydroxyapatite-bone interface: An experimental study in rabbits. Int J Oral Maxillofac Impl 1994;9:163-8.
199. Piattelli A, Trisi P. A light and laser scanning microscopy study of bone/hydroxyapatite-coated titanium implants interface: Histochemical evidence of unmineralized material in humans. J Biomed Mater Res 1994;28:529-36.
200. Bauer TW, Geesink RCT, Zimmerman R, McMahon JT. Hydroxyapatite-coated femoral stems. Histological analysis of component retrieved at autopsy. J Bone Joint Surg 1991;73-A:1439-52.
201. Soballe K, Gotfredsen K, Brockstedt-Rasmussen H, Nielsen PT, Rechnagel K. Histologic analysis of a retrieved hydroxyapatite-coated femoral prosthesis. Clin Orthop 1991;272:255-8.
202. De Lange GL, Donath K. Interface between bone tissue and implants of solid hydroxyapatite or hydroxyapatite-coated titanium implants. Biomaterials 1989;10:121-5.
203. Hemmerle J, Voegel J-C. Ultrastructural aspects of the intact titanium implant-bone interface from undecalcified ultrathin sections. Biomaterials 1996;17:1913-20.
204. Kim KJ, Kobayashi Y, Itoh T. Osteolysis model with continuous infusion of polyethylene particles. Clin Orthop 1998,352:46-52.
205. Granchi D, Stea S, Ciapetti G, Savarino L, Cavedagna D, Pizzoferrato A. In vitro effects of bone cements on the cell cycle of osteoblast-like cells. Biomaterials 1995;16:1187-92.
206. Fadda M, Zirattu G, De Santis E. Revisione a distanza della membrana di interfaccia osso-cemento nel tumore a cellule giganti dell'osso: Quadro istologico e aspetti ultrastrutturali. G It Ortop Traumatol 1996;22:453-60.
207. Cook SD, Thomas KA, Haddad JG jr. Histologic analysis of retrieved human porous-coated total joint components. Clin Orthop 1988;234:90-101.
208. Goldring SR, Schiller AL, Roelke M, Rourket CM, O'Neill D, Harris WH. The synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis. J Bone Joint Surg 1983;65-A:575-84.
209. Ohlin A, Kindblom L-G. The ultrastructure of the tissue surrounding the Christiansen total hip. Acta Orthop Scand 1988;59: 629-34.
210. Pazzaglia UE, Pringle JAS. Bone resorption in vitro: Macrophages and giant cells from failed total hip replacement versus osteoclasts. Biomaterials 1989;10:286-8.
211. Aspenberg P, Herbertsson P. Periprostetic bone resorption. Particles versus movement. J Bone Joint Surg 1996;78-B:641-6.
212. Ishizaka M, Tanizawa T, Sofue M, Dohmae Y, Endo N, Takahashi HE. Bone particles disturb new bone formation on the interface of the titanium implant after reaming of the marrow cavity. Bone 1996;19:589-94.
213. Fadda M, Espa E, Marceddu S, De Santis E. I detriti metallici nei fallimenti delle artroprotesi d'anca non cementate. Studio morfologico e ultrastrutturale. G It Ortop Traumatol 1996;22: 119-26.
214. Heilmann K, Diezel PB, Rossner JA, Brinkmann KA. Morphological studies in tissues surrounding alloarthroplastic joints. Virchows Arch A Pathol Anat Histol 1975;366:93-106.